Advertisement
Screener

NEUROCRINE BIOSCIENCES INC (NBIX) Preferred Stock, Shares Authorized

2.8 / 5 stars · 68/120 Roast Me

NEUROCRINE BIOSCIENCES INC Preferred Stock, Shares Authorized

NEUROCRINE BIOSCIENCES INC (NBIX) had Preferred Stock, Shares Authorized of 5.00 million shares as of 2026-06-30, per its 10-Q filed 2026-07-31.

Financial Statements › Balance Sheet › Equity › Stockholders' Equity, Number of Shares, Par Value and Other Disclosure › Preferred Stock, Number of Shares, Par Value and Other Disclosure

us-gaap:PreferredStockSharesAuthorized · last filed 2026-07-31

  • 2026-06-30: Preferred Stock, Shares Authorized 5.00M shares.
  • 2026-03-31: Preferred Stock, Shares Authorized 5.00M shares.
  • 2025-12-31: Preferred Stock, Shares Authorized 5.00M shares.
  • 2025-09-30: Preferred Stock, Shares Authorized 5.00M shares.
Period endPreferred Stock, Shares Authorized
2026-06-305.00M shares
10-Q · filed 2026-07-31
2026-03-315.00M shares
10-Q · filed 2026-05-05
2025-12-315.00M shares
10-Q · filed 2026-07-31
2025-09-305.00M shares
10-Q · filed 2025-10-28
2025-06-305.00M shares
10-Q · filed 2025-07-30
2025-03-315.00M shares
10-Q · filed 2025-05-05
2024-12-315.00M shares
10-K · filed 2026-02-11
2024-09-305.00M shares
10-Q · filed 2024-10-30
2024-06-305.00M shares
10-Q · filed 2024-08-01
2024-03-315.00M shares
10-Q · filed 2024-05-01
2023-12-315.00M shares
10-K · filed 2025-02-10
2023-09-305.00M shares
10-Q · filed 2023-10-31
2023-06-305.00M shares
10-Q · filed 2023-08-01
2023-03-315.00M shares
10-Q · filed 2023-05-03
2022-12-315.00M shares
10-K · filed 2024-02-09
2022-09-305.00M shares
10-Q · filed 2022-11-01
2022-06-305.00M shares
10-Q · filed 2022-08-04
2022-03-315.00M shares
10-Q · filed 2022-05-04
2021-12-315.00M shares
10-K · filed 2023-02-09
2021-09-305.00M shares
10-Q · filed 2021-11-01
2021-06-305.00M shares
10-Q · filed 2021-08-03
2021-03-315.00M shares
10-Q · filed 2021-05-05
2020-12-315.00M shares
10-K · filed 2022-02-11
2020-09-305.00M shares
10-Q · filed 2020-11-09
2020-06-305.00M shares
10-Q · filed 2020-08-03
2020-03-315.00M shares
10-Q · filed 2020-05-06
2019-12-315.00M shares
10-K · filed 2021-02-05
2019-09-305.00M shares
10-Q · filed 2019-11-04
2019-06-305.00M shares
10-Q · filed 2019-07-29
2019-03-315.00M shares
10-Q · filed 2019-04-29
2018-12-315.00M shares
10-K · filed 2020-02-07
2018-09-305.00M shares
10-Q · filed 2018-11-05
2018-06-305.00M shares
10-Q · filed 2018-07-31
2018-03-315.00M shares
10-Q · filed 2018-04-30
2017-12-315.00M shares
10-K · filed 2019-02-08
2017-09-305.00M shares
10-Q · filed 2017-11-01
2017-06-305.00M shares
10-Q · filed 2017-08-03
2017-03-315.00M shares
10-Q · filed 2017-05-09
2016-12-315.00M shares
10-K · filed 2018-02-13
2016-09-305.00M shares
10-Q · filed 2016-11-02
2016-06-305.00M shares
10-Q · filed 2016-08-03
2016-03-315.00M shares
10-Q · filed 2016-05-05
2015-12-315.00M shares
10-K · filed 2017-02-14
2015-09-305.00M shares
10-Q · filed 2015-10-29
2015-06-305.00M shares
10-Q · filed 2015-07-29
2015-03-315.00M shares
10-Q · filed 2015-04-30
2014-12-315.00M shares
10-K · filed 2016-02-11
2014-09-305.00M shares
10-Q · filed 2014-11-04
2014-06-305.00M shares
10-Q · filed 2014-08-06
2014-03-315.00M shares
10-Q · filed 2014-05-01
2013-12-315.00M shares
10-K · filed 2015-02-09
2013-09-305.00M shares
10-Q · filed 2013-10-29
2013-06-305.00M shares
10-Q · filed 2013-07-26
2013-03-315.00M shares
10-Q · filed 2013-05-02
2012-12-315.00M shares
10-K · filed 2014-02-11
2012-09-305.00M shares
10-Q · filed 2012-10-31
2012-06-305.00M shares
10-Q · filed 2012-07-31
2012-03-315.00M shares
10-Q · filed 2012-05-02
2011-12-315.00M shares
10-K · filed 2013-02-08
2011-09-305.00M shares
10-Q · filed 2011-10-31
2011-06-305.00M shares
10-Q · filed 2011-07-29
2010-12-315.00M shares
10-K · filed 2012-02-09

Similar stocks

Stock NameCountryMarket CapPE Ratio
EXELIXIS, INC. (EXEL)United States$14.358B16.15
HALOZYME THERAPEUTICS, INC. (HALO)United States$13.083B21.59
Twist Bioscience Corp (TWST)United States$11.540B-47.21
BIO-TECHNE Corp (TECH)United States$11.379B74.68
REPLIGEN CORP (RGEN)United States$10.755B185.31
Krystal Biotech, Inc. (KRYS)United States$10.210B45.56
Kymera Therapeutics, Inc. (KYMR)United States$9.631B-31.69
ImmunityBio, Inc. (IBRX)United States$9.157B-9.29
Vaxcyte, Inc. (PCVX)United States$8.466B-7.91
Immunovant, Inc. (IMVT)United States$7.028B-14.78